featured
Sustained Reduction in Hypoglycemia With the Use of CGM in Older Adults With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Diabetes Technol. Ther. 2022 Jun 01;24(6)424-434, KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, A Bhargava, BW Bode, A Carlson, NS Chaytor, G Gannon, R Goland, IB Hirsch, L Kiblinger, D Kruger, YC Kudva, CJ Levy, JB McGill, G O'Malley, AL Peters, LH Philipson, A Philis-Tsimikas, R Pop-Busui, M Salam, VN Shah, MJ Thompson, F Vendrame, A Verdejo, RS Weinstock, L Young, R PratleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.